|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/768 | (2015.01) |
| A61K 35/761 | (2013.01) | ||
| A61K 35/761 | (2015.01) | ||
| A61K 35/768 | (2013.01) | ||
| A61K 35/763 | (2015.01) | ||
| A61P 35/00 | (2018.01) | ||
| C12N2710/24132 | (2013.01) | ||
| A61K 35/765 | (2015.01) | ||
| A61K 35/766 | (2015.01) | ||
| C12N2710/10332 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 35/766 | (2013.01) | ||
| C12N 7/00 | (2006.01) | ||
| A61K 9/0019 | (2013.01) | ||
| C12R 1/93 | (2006.01) | ||
| A61K 39/4613 | (2023.05) | ||
| A61K2239/55 | (2023.05) | ||
| A61K 39/4644 | (2023.05) | ||
| A61K2239/54 | (2023.05) | ||
| A61K2239/50 | (2023.05) | ||
| A61K2239/38 | (2023.05) | ||
| A61K2239/53 | (2023.05) |
| (11) | Number of the document | 3566709 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18736087.0 |
| Date of filing the European patent application | 2018-01-03 | |
| (97) | Date of publication of the European application | 2019-11-13 |
| (45) | Date of publication and mention of the grant of the patent | 2024-09-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2018/070172 |
| Date | 2018-01-03 |
| (87) | Number | WO 2018/127053 |
| Date | 2018-07-12 |
| (30) | Number | Date | Country code |
| 201710003954 | 2017-01-04 | CN |
| (72) |
HU, Fang , CN
CHEN, Lin , CN
ZHAO, Ronghua , CN
|
| (73) |
Hangzhou Converd Co., Ltd. ,
7th Floor, Building No.4,
2959 Yuhangtang Road,
Yuhang District, Hangzhou, Zhejiang 311121,
CN
|
| (54) | THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CELLS, AND USES THEREOF FOR DRUGS FOR TREATMENT OF TUMORS AND/OR CANCERS |
| THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CELLS, AND USES THEREOF FOR DRUGS FOR TREATMENT OF TUMORS AND/OR CANCERS |